- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about IMGN
Recent news which mentions IMGN
Earnings Scheduled For May 6, 2022
May 06, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
75 Biggest Movers From Yesterday
March 22, 2022
From Benzinga
Why Coinbase and Immunogen Led the Nasdaq Lower Monday
March 21, 2022
From Motley Fool
12 Health Care Stocks Moving In Monday's Intraday Session
March 21, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
March 21, 2022
From Benzinga
46 Stocks Moving In Monday's Mid-Day Session
March 21, 2022
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 21, 2022
From Benzinga
Why Are ImmunoGen Shares Trading Lower Today
March 21, 2022
From Benzinga
From InvestorPlace
28 Stocks Moving in Monday's Pre-Market Session
March 21, 2022
From Benzinga
The Daily Biotech Pulse: Lilly's Jardiance Gets Nod For Heart Failure, Pulmatrix Announces Reverse Split, Reata Awaits FDA Decision
February 25, 2022
From Benzinga
Earnings Scheduled For February 25, 2022
February 25, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
Lilly Unites With ImmunoGen In ADC Deal Worth Up To $1.7B
February 15, 2022
From Benzinga
Why Sutro Biopharma Stock Is Losing Ground Today
January 06, 2022
From Motley Fool
Why Shares of ImmunoGen Jumped 20.3% in December
January 03, 2022
From Motley Fool
3 Under-the-Radar Biotech Stocks to Buy in 2022
December 11, 2021
From Motley Fool
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
From Benzinga
61 Biggest Movers From Yesterday
December 02, 2021
From Benzinga
Why Adaptimmune Therapeutics Stock Is Crashing Today
December 01, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.